Abstract
We describe a boy who presented at the age of 7 years with short stature due to hypopituitarism. Six months after starting appropriate hormone replacement treatment at the age of 8 he suffered his first generalised convulsion. Further neuroradiological investigation led to the diagnosis of moyamoya syndrome. Moyamoya is the arteriographic appearance of a filmy network of small vessels at the termination of the internal carotid artery. We describe a boy with hypopituitarism associated with moyamoya.
Case report
The boy presented initially to our hospital at 18 months of age with obesity and developmental delay. He was the fifth child of unrelated, white parents (maternal height 0 SD, paternal height -09 SD) and was born at term by spontaneous vaginal delivery. The birth weight was 3450 g and there were no perinatal problems. The developmental delay was thought to be due to lack of parental stimulation and a physiotherapy programme was devised with support for the family. At 3 years of age he was admitted to hospital for investigation of persistent lower limb weakness but biochemical investigation excluded a myopathy. The family subsequently failed to attend hospital appointments.
At 7 years he was referred to the endocrine clinic with short stature, small genitalia, and headaches. On examination he was moderately obese with weight on the 25th percentile and height well below the 3rd percentile (-3-1 SD). There were no dysmorphic features. Blood pressure was 95/60 mm Hg. Fundoscopy and visual fields to confrontation were normal. He was alert and cooperative but clumsy with reduced power and tone in the lower limbs with tendon reflexes preserved and flexor plantars. His penis was small and the testes were less than 1 ml volume.
Investigation showed a TW2 bone age of 3-4 years at chronological age 7-1 years. Anterior Treatment with growth hormone and thyroxine was started at the age of 7-4 years resulting in a rise in growth velocity from 2-3 cm year in the four years before treatment to 9-8 cm in one year on treatment. At 7-9 years he suffered his first generalised seizure and an electroencephalogram confirmed epileptiform activity. A radiograph of the skull showed amputation of the dorsum sellae; computed tomography showed a shallow pituitary fossa and suprasellar calcifications with obliteration of the cisternae but no well defined soft tissue mass. The third ventricle was deviated slightly to the left side. The radiological findings were not considered to be sufficient for diagnosis but the possibility of a craniopharyngioma was discussed. The seizures were controlled with carbamazepine and a magnetic resonance scan requested to allow better definition of the suspected tumour. Subsequently the child developed worsening headaches and at 8 4 years of age was admitted to hospital with blurred vision, ataxia, and increased seizure frequency. A repeat computed tomogram confirmed suprasellar calcification with highly attenuating tumour like tissue in the suprasellar region, now also extending to the ambient cisterns with F i i i i ĩ~.# . ! . . . . . . . . . . . . . . . . . . . . . . . . of stenosis or occlusion of the internal carotid artery,2 usually bilateral, with development of a prolific collateral vascular network.3 It is the angiographic appearance that lead to Japanese authors referring to this as 'moyamoya', meaning 'puff of smoke'.
Similar neuroradiological appearances may be encountered with a variety of associated pathological entities. The syndrome has been reported in phakomatoses, septic infection of the head and neck, and tuberculous meningitis. Autoimmune diseases, peripheral vascular occlusive disease, head trauma, sickle cell disease, Fanconi's anaemia, intracranial aneurysm, arterial hypertension, brain irradiation, and chromosomal aberration have also been associated in reported cases.2 16 However, despite various hypotheses the aetiology of moyamoya remains unclear. The vast majority of cases, as in our case reported here, have no obvious cause for the vascular occlusion and the prognosis therefore can not be assessed on a firm pathological basis.
The exact association between the moyamoya syndrome and our patient's growth failure remains unclear but in view of the delayed bone age and pretreatment SD score of -3 1 it must be longstanding. As the initial computed tomogram showed a shallow pituitary fossa with suprasellar calcification, it seems likely that the space occupying vascular mass responsible for those appearances was also responsible for the pituitary dysfunction and growth failure.
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